Although diabetic patients commonly use metformin, GLP-1R agonists serve as a beneficial therapeutic option for diabetic patients with metformin intolerance
Week-by-week tracking template For each injection, record the following: Date and time of injection Dose in mg (prescribed amount) Concentration of vial (mg/ml) Units drawn on syringe Injection site (rotate between abdomen, thigh, upper arm) Side effects (none, mild, moderate, severe) Weight (weekly, same scale, same conditions) Notes (food tolerance, energy levels, appetite changes) This data becomes invaluable when making titration decisions with your provider
Degradation of amylin by insulin-degrading enzyme
Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
From that biology, researchers draw a theoretical concern: chronically potentiating a proliferative, pro-angiogenic pathway is a plausible mechanism by which an agent could, in principle, support growth of existing malignancy